Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SENSIENT TECHNOLOGIES CORPSXT · Entity 3822 | Director | September 30, 2026 | October 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SENSIENT TECHNOLOGIES CORP
Report date September 30, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred StockSEC Table II · derivative / convertible security | Direct | 24,516.786 |
Reported balance
After 2026-09-30 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-30 · Grant · Acquired 279.414 · Balance 24,516.786 F2: Deferred stock converts to common stock on a one-for-one basis. F3: Deferral of director fees under Issuer's Directors' Deferred Compensation Plan. F4: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. |
| Common StockSEC Table I · non-derivative | Direct | 23,789.02 |
Reported balance
Holding disclosure · report date 2026-09-30 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 23,789.02 F1: Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.
F2: Deferred stock converts to common stock on a one-for-one basis.
F3: Deferral of director fees under Issuer's Directors' Deferred Compensation Plan.
F4: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Avid Bioservices, Inc.
Report date February 05, 2025 · Filed February 07, 2025
Section 16 reporting ended · disclosed 2025-02-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.001 par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-02-05 transaction · row 1
1 source rowRow 1 · 2025-02-05 · Disposition to issuer · Disposed 130,324 · Balance 0 F1: Represents shares of common stock that were disposed of at the effective time (the "Effective Time") of the merger (the "Merger") of Space Mergerco, Inc. ("Merger Sub") with and into Avid Bioservices, Inc. (the "Issuer") pursuant to the Agreement and Plan of Merger, dated as of November 6, 2024 (the "Merger Agreement"), by and among the Issuer, Space Finco, Inc., and Merger Sub. F2: At the Effective Time, each outstanding share of common stock was cancelled and converted into the right to receive a cash payment per share of $12.50, without interest, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration"). |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.67 · Expires 2027-11-27 | Direct | 49,305 |
Reported balance
After 2025-02-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-02-05 · Disposition to issuer · Disposed 75,000 · Balance 49,305 F3: Represents stock options ("Options") that were disposed of at the Effective Time of the Merger of Merger Sub with and into the Issuer pursuant to the Merger Agreement, by and among the Issuer, Space Finco, Inc., and Merger Sub. F4: This Option was fully vested at the Effective Time. At the Effective Time, each fully vested Option was cancelled and converted solely into the right to receive a cash payment equal to the product of (a) the total number of shares of common stock subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over the per share exercise price of such vested Option, without interest, subject to the terms and conditions of the Merger Agreement. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.22 · Expires 2025-12-14 | Direct | 29,705 |
Reported balance
After 2025-02-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-02-05 · Disposition to issuer · Disposed 19,600 · Balance 29,705 F3: Represents stock options ("Options") that were disposed of at the Effective Time of the Merger of Merger Sub with and into the Issuer pursuant to the Merger Agreement, by and among the Issuer, Space Finco, Inc., and Merger Sub. F4: This Option was fully vested at the Effective Time. At the Effective Time, each fully vested Option was cancelled and converted solely into the right to receive a cash payment equal to the product of (a) the total number of shares of common stock subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over the per share exercise price of such vested Option, without interest, subject to the terms and conditions of the Merger Agreement. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.87 · Expires 2027-01-09 | Direct | 10,030 |
Reported balance
After 2025-02-05 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-02-05 · Disposition to issuer · Disposed 19,675 · Balance 10,030 F3: Represents stock options ("Options") that were disposed of at the Effective Time of the Merger of Merger Sub with and into the Issuer pursuant to the Merger Agreement, by and among the Issuer, Space Finco, Inc., and Merger Sub. F4: This Option was fully vested at the Effective Time. At the Effective Time, each fully vested Option was cancelled and converted solely into the right to receive a cash payment equal to the product of (a) the total number of shares of common stock subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over the per share exercise price of such vested Option, without interest, subject to the terms and conditions of the Merger Agreement. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.72 · Expires 2027-12-14 | Direct | 0 |
Reported balance
After 2025-02-05 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-02-05 · Disposition to issuer · Disposed 10,030 · Balance 0 F3: Represents stock options ("Options") that were disposed of at the Effective Time of the Merger of Merger Sub with and into the Issuer pursuant to the Merger Agreement, by and among the Issuer, Space Finco, Inc., and Merger Sub. F4: This Option was fully vested at the Effective Time. At the Effective Time, each fully vested Option was cancelled and converted solely into the right to receive a cash payment equal to the product of (a) the total number of shares of common stock subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over the per share exercise price of such vested Option, without interest, subject to the terms and conditions of the Merger Agreement. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2025-02-05 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-02-05 · Disposition to issuer · Disposed 8,147 · Balance 0 F5: Represents restricted stock units ("RSUs") that were disposed of at the Effective Time of the Merger of Merger Sub with and into the Issuer pursuant to the Merger Agreement, by and among the Issuer, Space Finco, Inc., and Merger Sub. F6: At the Effective Time, each unvested RSU was cancelled and converted solely into the right to receive a cash payment of $12.50 per share of common stock subject to such unvested RSU, without interest, subject to the terms and conditions of the Merger Agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock that were disposed of at the effective time (the "Effective Time") of the merger (the "Merger") of Space Mergerco, Inc. ("Merger Sub") with and into Avid Bioservices, Inc. (the "Issuer") pursuant to the Agreement and Plan of Merger, dated as of November 6, 2024 (the "Merger Agreement"), by and among the Issuer, Space Finco, Inc., and Merger Sub.
F2: At the Effective Time, each outstanding share of common stock was cancelled and converted into the right to receive a cash payment per share of $12.50, without interest, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration").
F3: Represents stock options ("Options") that were disposed of at the Effective Time of the Merger of Merger Sub with and into the Issuer pursuant to the Merger Agreement, by and among the Issuer, Space Finco, Inc., and Merger Sub.
F4: This Option was fully vested at the Effective Time. At the Effective Time, each fully vested Option was cancelled and converted solely into the right to receive a cash payment equal to the product of (a) the total number of shares of common stock subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over the per share exercise price of such vested Option, without interest, subject to the terms and conditions of the Merger Agreement.
F5: Represents restricted stock units ("RSUs") that were disposed of at the Effective Time of the Merger of Merger Sub with and into the Issuer pursuant to the Merger Agreement, by and among the Issuer, Space Finco, Inc., and Merger Sub.
F6: At the Effective Time, each unvested RSU was cancelled and converted solely into the right to receive a cash payment of $12.50 per share of common stock subject to such unvested RSU, without interest, subject to the terms and conditions of the Merger Agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 14, 2020 Filed Dec 16, 2020 19:59 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | GrantRestricted Stock Units · Derivative | 2,379 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-20-004315 · ownership.xml · derivative · entry 2 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,379 Underlying: Common Stock · 2,379 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's Common Stock. F1 · shares: Annual grant of equity awards pursuant to the Issuer's non-employee director compensation program. F2 · derivative.exercise_date: 100% of each equity award granted to the reporting person shall vest on December 14, 2021. F2 · derivative.expiration_date: 100% of each equity award granted to the reporting person shall vest on December 14, 2021. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 19:59 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | GrantStock Option (right to buy) · Derivative | 10,030 | $0.00 Strike: $10.72 | $0.00 |
DisclosureSEC source: 0001683168-20-004315 · ownership.xml · derivative · entry 1 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,305 Underlying: Common Stock · 10,030 shares Expires 2027-12-14 F1 · shares: Annual grant of equity awards pursuant to the Issuer's non-employee director compensation program. F2 · derivative.exercise_date: 100% of each equity award granted to the reporting person shall vest on December 14, 2021. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 17:51 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantDeferred Stock · Derivative | 571.961 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026142 · form4.xml · derivative · entry 2 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,764.16 Underlying: Common Stock · 571.961 shares Expires not disclosed F2 · derivative.exercise_price: Deferred stock converts to common stock on a one-for-one basis. F3 · kind: Deferral of director fees under Issuer's Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. F4 · derivative.expiration_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 19:39 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantDeferred Stock · Derivative | 633.148 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-020853 · form4.xml · derivative · entry 2 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,115.955 Underlying: Common Stock · 633.148 shares Expires not disclosed F2 · derivative.exercise_price: Deferred stock converts to common stock on a one-for-one basis. F3 · kind: Deferral of director fees under Issuer's Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. F4 · derivative.expiration_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. Read SEC document |
| April 23, 2020 Filed Apr 24, 2020 20:32 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantCommon Stock | 2,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014441 · form4.xml · nonDerivative · entry 1 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,787.374 F1 · kind: Represents grant of restricted stock under Issuer's 2012 Non-Employee Directors Stock Plan. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan. Read SEC document |
| March 31, 2020 Filed Apr 1, 2020 22:22 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantDeferred Stock · Derivative | 759.021 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-012458 · form4.xml · derivative · entry 2 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,402.17 Underlying: Common Stock · 759.021 shares Expires not disclosed F2 · derivative.exercise_price: Deferred stock converts to common stock on a one-for-one basis. F3 · kind: Deferral of director fees under Issuer's Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. F4 · derivative.expiration_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. Read SEC document |
| March 13, 2020 Filed Mar 16, 2020 15:25 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | PurchaseCommon Stock, $0.001 par value | 12,500 | $4.01 | $50,125.00 |
DisclosureSEC source: 0001683168-20-000828 · ownership.xml · nonDerivative · entry 1 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,945 Read SEC document |
| February 18, 2020 Filed Feb 18, 2020 22:01 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | PurchaseCommon Stock | 2,000 | $55.65 | $111,300.00 |
DisclosureSEC source: 0001127602-20-006111 · form4.xml · nonDerivative · entry 1 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,694.675 F1 · balance_after: Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan. Read SEC document |
| January 09, 2020 Filed Jan 13, 2020 20:34 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | GrantStock Option (right to buy) · Derivative | 19,675 | $0.00 Strike: $6.87 | $0.00 |
DisclosureSEC source: 0001683168-20-000106 · ownership.xml · derivative · entry 1 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,275 Underlying: Common Stock · 19,675 shares Expires 2027-01-09 F1 · shares: Annual grant of stock options pursuant to the Issuer's non-employee director compensation program. F2 · derivative.exercise_date: This option fully vests one year from the date of grant. Read SEC document |
| December 31, 2019 Filed Jan 2, 2020 21:05 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantDeferred Stock · Derivative | 450.522 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-000125 · form4.xml · derivative · entry 2 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,569.81 Underlying: Common Stock · 450.522 shares Expires not disclosed F2 · derivative.exercise_price: Deferred stock converts to common stock on a one-for-one basis. F3 · kind: Deferral of director fees under Issuer's Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. F4 · derivative.expiration_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. Read SEC document |
| September 30, 2019 Filed Oct 1, 2019 22:00 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantDeferred Stock · Derivative | 433.722 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-029490 · form4.xml · derivative · entry 2 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,068.405 Underlying: Common Stock · 433.722 shares Expires not disclosed F2 · derivative.exercise_price: Deferred stock converts to common stock on a one-for-one basis. F3 · kind: Deferral of director fees under Issuer's Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. F4 · derivative.expiration_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. Read SEC document |
| September 10, 2019 Filed Sep 12, 2019 15:03 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | PurchaseCommon Stock, $0.001 par value | 5,000 | $5.10 | $25,500.00 |
DisclosureSEC source: 0001683168-19-002898 · ownership.xml · nonDerivative · entry 2 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,445 Read SEC document |
| September 10, 2019 Filed Sep 12, 2019 15:03 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | PurchaseCommon Stock, $0.001 par value | 5,000 | $5.00 | $25,000.00 |
DisclosureSEC source: 0001683168-19-002898 · ownership.xml · nonDerivative · entry 1 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,445 Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 16:42 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantDeferred Stock · Derivative | 405.212 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-023390 · form4.xml · derivative · entry 2 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,586.504 Underlying: Common Stock · 405.212 shares Expires not disclosed F2 · derivative.exercise_price: Deferred stock converts to common stock on a one-for-one basis. F3 · kind: Deferral of director fees under Issuer's Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. F4 · derivative.expiration_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. Read SEC document |
| April 25, 2019 Filed Apr 26, 2019 21:05 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantCommon Stock | 1,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-016330 · form4.xml · nonDerivative · entry 1 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,582.981 F1 · kind: Represents grant of restricted stock under Issuer's 2012 Non-Employee Directors Stock Plan. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan. Read SEC document |
| March 31, 2019 Filed Apr 2, 2019 20:13 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantDeferred Stock · Derivative | 439.224 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-014130 · form4.xml · derivative · entry 2 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,138.258 Underlying: Common Stock · 439.224 shares Expires not disclosed F2 · derivative.exercise_price: Deferred stock converts to common stock on a one-for-one basis. F3 · kind: Deferral of director fees under Issuer's Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. F4 · derivative.expiration_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. Read SEC document |
| December 31, 2018 Filed Jan 2, 2019 22:36 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantDeferred Stock · Derivative | 533.124 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-000369 · form4.xml · derivative · entry 2 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,656.937 Underlying: Common Stock · 533.124 shares Expires not disclosed F2 · derivative.exercise_price: Deferred stock converts to common stock on a one-for-one basis. F3 · kind: Deferral of director fees under Issuer's Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. F4 · derivative.expiration_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 20:17 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | GrantStock Option (right to buy) · Derivative | 19,600 | $0.00 Strike: $5.22 | $0.00 |
DisclosureSEC source: 0001683168-18-003740 · ownership.xml · derivative · entry 1 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,600 Underlying: Common Stock · 19,600 shares Expires 2025-12-14 F1 · derivative.exercise_date: This option fully vests one year from the date of grant. Read SEC document |
| October 23, 2018 Filed Oct 25, 2018 21:14 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | PurchaseCommon Stock | 1,000 | $64.63 | $64,630.00 |
DisclosureSEC source: 0001127602-18-031018 · form4.xml · nonDerivative · entry 1 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,242.51 F1 · price: This amount represents the weighted average sale price for the transactions reported on this line. The actual sale prices ranged from $64.60 to $64.64. The reporting person hereby agrees to provide, upon request by the SEC staff, by the Issuer, or by any security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan. Read SEC document |
| September 30, 2018 Filed Oct 1, 2018 21:07 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantDeferred Stock · Derivative | 389.165 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-028798 · form4.xml · derivative · entry 2 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,083.794 Underlying: Common Stock · 389.165 shares Expires not disclosed F2 · derivative.exercise_price: Deferred stock converts to common stock on a one-for-one basis. F3 · kind: Deferral of director fees under Issuer's Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. F4 · derivative.expiration_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. Read SEC document |
| June 30, 2018 Filed Jul 2, 2018 20:25 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantDeferred Stock · Derivative | 416.143 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-022214 · form4.xml · derivative · entry 2 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,663.713 Underlying: Common Stock · 416.143 shares Expires not disclosed F2 · derivative.exercise_price: Deferred stock converts to common stock on a one-for-one basis. F3 · kind: Deferral of director fees under Issuer's Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. F4 · derivative.expiration_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. Read SEC document |
| April 26, 2018 Filed Apr 27, 2018 21:37 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantCommon Stock | 1,310 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-015445 · form4.xml · nonDerivative · entry 1 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,193.373 F1 · kind: Represents grant of restricted stock under Issuer's 2012 Non-Employee Directors Stock Plan. F1 · price: Represents grant of restricted stock under Issuer's 2012 Non-Employee Directors Stock Plan. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan. Read SEC document |
| March 31, 2018 Filed Apr 2, 2018 22:10 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantDeferred Stock · Derivative | 432.488 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-013403 · form4.xml · derivative · entry 2 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,217.13 Underlying: Common Stock · 432.488 shares Expires not disclosed F2 · derivative.exercise_price: Deferred stock converts to common stock on a one-for-one basis. F3 · kind: Deferral of director fees under Issuer's Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. F4 · derivative.expiration_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 18:14 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | PurchaseCommon Stock, $0.001 par value | 44,445 | $2.25 | $100,001.25 |
DisclosureSEC source: 0001683168-18-000477 · carleone_f4.xml · nonDerivative · entry 1 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,445 F1 · shares: Purchase of shares in an underwritten public offering at the price paid by the public. The shares are subject to a lock-up provision for a period of 90 days, as required under a lock-up agreement with the underwriters of the public offering. Read SEC document |
| December 31, 2017 Filed Jan 2, 2018 23:49 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantDeferred Stock · Derivative | 581.34 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-000225 · form4.xml · derivative · entry 2 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,757.918 Underlying: Common Stock · 581.34 shares Expires not disclosed F2 · derivative.exercise_price: Deferred stock converts to common stock on a one-for-one basis. F3 · kind: Deferral of director fees under Issuer's Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. F4 · derivative.expiration_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. Read SEC document |
| November 27, 2017 Filed Nov 29, 2017 20:05 UTC | Avid Bioservices, Inc. PPHM · Entity 83494 | GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $4.67 | $0.00 |
DisclosureSEC source: 0001683168-17-003186 · carleone_frm4.xml · derivative · entry 1 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2027-11-27 F1 · derivative.exercise_date: This option vests in thirty-six (36) equal monthly installments over a three (3) year period beginning December 27, 2017. Read SEC document |
| September 30, 2017 Filed Oct 2, 2017 21:25 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantDeferred Stock · Derivative | 302.262 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-028676 · form4.xml · derivative · entry 2 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,154.541 Underlying: Common Stock · 302.262 shares Expires not disclosed F2 · derivative.exercise_price: Deferred stock converts to common stock on a one-for-one basis. F3 · kind: Deferral of director fees under Issuer's Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. F4 · derivative.expiration_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. Read SEC document |
| July 24, 2017 Filed Jul 24, 2017 20:20 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | PurchaseCommon Stock | 1,000 | $75.32 | $75,323.80 |
DisclosureSEC source: 0001127602-17-024053 · form4.xml · nonDerivative · entry 1 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,833.566 F1 · balance_after: Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 17:50 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantDeferred Stock · Derivative | 270.086 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-022762 · form4.xml · derivative · entry 2 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,714.419 Underlying: Common Stock · 270.086 shares Expires not disclosed F2 · derivative.exercise_price: Deferred stock converts to common stock on a one-for-one basis. F3 · kind: Deferral of director fees under Issuer's Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. F4 · derivative.expiration_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. Read SEC document |
| June 30, 2017 Filed Sep 12, 2017 21:06 UTC Amendment | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantDeferred Stock · Derivative | 388.054 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-027342 · form4a.xml · derivative · entry 1 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,832.387 Underlying: Common Stock · 388.054 shares Expires not disclosed F1 · derivative.exercise_price: Deferred stock converts to common stock on a one-for-one basis. F2 · kind: Deferral of director fees under Issuer's Directors' Deferred Compensation Plan. F3 · shares: The original Form 4 filed on 7/5/17 erroneously reported the number as 270.086. The correct number is 388.054. All other line items previously reported on the original Form 4 have been omitted from this Form 4/A as they have not changed. F4 · derivative.exercise_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. F4 · derivative.expiration_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. Read SEC document |
| April 27, 2017 Filed Apr 28, 2017 22:33 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantCommon Stock | 1,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-015901 · form4.xml · nonDerivative · entry 1 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,819.582 F1 · kind: Represents grant of restricted stock under Issuer's 2012 Non-Employee Directors Stock Plan. F1 · price: Represents grant of restricted stock under Issuer's 2012 Non-Employee Directors Stock Plan. F2 · balance_after: Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan. Read SEC document |
| March 31, 2017 Filed Apr 28, 2017 22:33 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantDeferred Stock · Derivative | 369.039 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-015901 · form4.xml · derivative · entry 2 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,425.229 Underlying: Common Stock · 369.039 shares Expires not disclosed F3 · derivative.exercise_price: Deferred stock converts to common stock on a one-for-one basis. F4 · kind: Deferral of director fees under Issuer's Directors' Deferred Compensation Plan. F5 · derivative.exercise_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. F5 · derivative.expiration_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. Read SEC document |
| December 31, 2016 Filed Jan 3, 2017 21:33 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantDeferred Stock · Derivative | 410.41 | $78.58 | $32,250.02 |
DisclosureSEC source: 0001127602-17-000226 · form4.xml · derivative · entry 2 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,042.732 Underlying: Common Stock · 410.41 shares Expires not disclosed F2 · derivative.exercise_price: Deferred stock converts to common stock on a one-for-one basis. F3 · kind: Deferral of director fees under Issuer's Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. F4 · derivative.expiration_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 21:44 UTC | SENSIENT TECHNOLOGIES CORP SXT · Entity 3822 | GrantDeferred Stock · Derivative | 326.517 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-063733 · form4.xml · derivative · entry 2 CARLEONE JOSEPH · CIK 0001212515 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,662.088 Underlying: Common Stock · 326.517 shares Expires not disclosed F2 · derivative.exercise_price: Deferred stock converts to common stock on a one-for-one basis. F3 · kind: Deferral of director fees under Issuer's Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. F4 · derivative.expiration_date: Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.